319 related articles for article (PubMed ID: 26406890)
1. Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor.
Gouveia-Figueira S; Karlsson J; Deplano A; Hashemian S; Svensson M; Fredriksson Sundbom M; Congiu C; Onnis V; Fowler CJ
PLoS One; 2015; 10(9):e0139212. PubMed ID: 26406890
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen.
Cipriano M; Björklund E; Wilson AA; Congiu C; Onnis V; Fowler CJ
Eur J Pharmacol; 2013 Nov; 720(1-3):383-90. PubMed ID: 24120370
[TBL] [Abstract][Full Text] [Related]
3. Interaction of the N-(3-Methylpyridin-2-yl)amide Derivatives of Flurbiprofen and Ibuprofen with FAAH: Enantiomeric Selectivity and Binding Mode.
Karlsson J; Morgillo CM; Deplano A; Smaldone G; Pedone E; Luque FJ; Svensson M; Novellino E; Congiu C; Onnis V; Catalanotti B; Fowler CJ
PLoS One; 2015; 10(11):e0142711. PubMed ID: 26565710
[TBL] [Abstract][Full Text] [Related]
4. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol.
Ho WS; Randall MD
Br J Pharmacol; 2007 Mar; 150(5):641-51. PubMed ID: 17245358
[TBL] [Abstract][Full Text] [Related]
5. Interaction of endocannabinoid system and cyclooxygenase metabolites with fatty acid amide hydrolase and cyclooxygenase enzyme activities on contractile responses in rat vas deferens tissue.
Vural EH; Ozturk Fincan GS; Okcay Y; Askin CI; Gudul Bacanli M; Vural IM
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4123-4137. PubMed ID: 38032490
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide.
Fowler CJ; Björklund E; Lichtman AH; Naidu PS; Congiu C; Onnis V
J Enzyme Inhib Med Chem; 2013 Feb; 28(1):172-82. PubMed ID: 22225576
[TBL] [Abstract][Full Text] [Related]
7. A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes.
Rockwell CE; Kaminski NE
J Pharmacol Exp Ther; 2004 Nov; 311(2):683-90. PubMed ID: 15284281
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and
Deplano A; Karlsson J; Moraca F; Svensson M; Cristiano C; Morgillo CM; Fowler CJ; Russo R; Catalanotti B; Onnis V
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):940-953. PubMed ID: 33896320
[TBL] [Abstract][Full Text] [Related]
9. Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen.
Deplano A; Karlsson J; Svensson M; Moraca F; Catalanotti B; Fowler CJ; Onnis V
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):815-823. PubMed ID: 32200655
[TBL] [Abstract][Full Text] [Related]
10. Dual cyclooxygenase-fatty acid amide hydrolase inhibitor exploits novel binding interactions in the cyclooxygenase active site.
Goodman MC; Xu S; Rouzer CA; Banerjee S; Ghebreselasie K; Migliore M; Piomelli D; Marnett LJ
J Biol Chem; 2018 Mar; 293(9):3028-3038. PubMed ID: 29326169
[TBL] [Abstract][Full Text] [Related]
11. Effects of tumour necrosis factor α upon the metabolism of the endocannabinoid anandamide in prostate cancer cells.
Karlsson J; Gouveia-Figueira S; Alhouayek M; Fowler CJ
PLoS One; 2017; 12(9):e0185011. PubMed ID: 28910408
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of endocannabinoid metabolism by the metabolites of ibuprofen and flurbiprofen.
Karlsson J; Fowler CJ
PLoS One; 2014; 9(7):e103589. PubMed ID: 25061885
[TBL] [Abstract][Full Text] [Related]
13. The fatty acid amide hydrolase and cyclooxygenase-inhibitory properties of novel amide derivatives of carprofen.
Deplano A; Karlsson J; Fowler CJ; Onnis V
Bioorg Chem; 2020 Aug; 101():104034. PubMed ID: 32599361
[TBL] [Abstract][Full Text] [Related]
14. The effects of fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on lipopolysaccharide-induced airway inflammation in mice.
Abohalaka R; Bozkurt TE; Nemutlu E; Onder SC; Sahin-Erdemli I
Pulm Pharmacol Ther; 2020 Jun; 62():101920. PubMed ID: 32416152
[TBL] [Abstract][Full Text] [Related]
15. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.
Sun YX; Tsuboi K; Zhao LY; Okamoto Y; Lambert DM; Ueda N
Biochim Biophys Acta; 2005 Oct; 1736(3):211-20. PubMed ID: 16154384
[TBL] [Abstract][Full Text] [Related]
16. Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake?
Fowler CJ; Ghafouri N
Pharmacol Res; 2008 Jul; 58(1):72-6. PubMed ID: 18675915
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.
Holt S; Paylor B; Boldrup L; Alajakku K; Vandevoorde S; Sundström A; Cocco MT; Onnis V; Fowler CJ
Eur J Pharmacol; 2007 Jun; 565(1-3):26-36. PubMed ID: 17397826
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.
Vandevoorde S; Fowler CJ
Br J Pharmacol; 2005 Aug; 145(7):885-93. PubMed ID: 15895107
[TBL] [Abstract][Full Text] [Related]
19. The 'specific' tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake.
Thors L; Alajakku K; Fowler CJ
Br J Pharmacol; 2007 Apr; 150(7):951-60. PubMed ID: 17325653
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells.
Li H; Wood JT; Whitten KM; Vadivel SK; Seng S; Makriyannis A; Avraham HK
Br J Pharmacol; 2013 Oct; 170(3):489-505. PubMed ID: 23347118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
